Fulgent Genetics Reports Record Third Quarter 2020 Financial Results and Raises Full Year 2020 Revenue Guidance by $100 Million
Third Quarter 2020 Results: Record Revenue of $101.7 million, growing more than 880% year-over-year Record Billable tests delivered approximately 1.04 million, growing more than 4,800% year-over-year Gross Margin improved approximately 19 percentage points …